| 11/16/2026 10:52 AM | Immunome (1472012) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G | |
| 11/09/2026 4:00 PM | Immunome (1472012) Filer | Form S-3ASR | |
| 11/09/2026 3:56 PM | Immunome (1472012) Filer | Form S-3ASR | |
| 11/09/2026 3:10 PM | Immunome (1472012) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/30/2026 11:05 AM | Immunome (1472012) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 10/05/2026 7:30 AM | Immunome (1472012) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2026 3:30 PM | Higgins Jack (1993684) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2026 9:20 AM | Higgins Jack (1993684) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2026 7:34 AM | Immunome (1472012) Subject Sirenia Capital Management LP (2115022) Filed by | Form SCHEDULE 13G/A | |
| 08/12/2026 4:47 PM | Barchas Isaac (1808343) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2026 10:40 AM | Barchas Isaac (1808343) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for IMNM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immunome and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/11/2026 3:22 PM | Immunome (1472012) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/11/2026 3:05 PM | Immunome (1472012) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2026 5:30 PM | Horn Kinney (1831215) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 4:41 PM | ABHMC II, LLC (2129593) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/04/2026 3:32 PM | Horn Kinney (1831215) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/09/2026 4:38 PM | Horn Kinney (1831215) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 6:02 PM | Barchas Isaac (1808343) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 4:42 PM | Immunome (1472012) Issuer Lechleider Robert (1997584) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 3:04 PM | Horn Kinney (1831215) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/06/2026 4:37 PM | ABHMC II, LLC (2129593) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/02/2026 7:31 PM | Barchas Isaac (1808343) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 3:42 PM | ABHMC II, LLC (2129593) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/02/2026 11:07 AM | Immunome (1472012) Subject Lechleider Robert (1997584) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/30/2026 4:20 PM | Arsenal Bridge Venture II-B, LLC (1976418) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/30/2026 4:20 PM | ABHMC II, LLC (2129593) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/25/2026 8:47 AM | Immunome (1472012) Subject Lechleider Robert (1997584) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/17/2026 4:26 PM | Immunome (1472012) Issuer Rosett Max (1994071) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 1:36 PM | Immunome (1472012) Subject Rosett Max (1994071) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/12/2026 4:54 PM | BIENAIME JEAN JACQUES (1221590) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:56 PM | Immunome (1472012) Issuer WAGENHEIM PHILIP (1405684) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:58 PM | Immunome (1472012) Issuer SWAIN SANDRA M (1908755) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:45 PM | Immunome (1472012) Issuer SCHAFER CAROL (1272181) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:48 PM | Barchas Isaac (1808343) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:51 PM | Boylan James P (1953094) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 3:05 PM | Immunome (1472012) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2026 4:40 PM | BIENAIME JEAN JACQUES (1221590) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 6:56 AM | BIENAIME JEAN JACQUES (1221590) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 3:15 PM | Immunome (1472012) Subject Redmile Group, LLC (1425738) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 9:06 AM | Immunome (1472012) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 7:16 AM | Immunome (1472012) Subject Sirenia Capital Management LP (2115022) Filed by | Form SCHEDULE 13G | |
Today's free pick (on me) (Ad) Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company.
With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th. Get today's free pick before December 8th. |
| 05/12/2026 3:05 PM | Immunome (1472012) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 3:05 PM | Immunome (1472012) Filer | Form DEF 14A | |
| 04/24/2026 3:06 PM | Immunome (1472012) Filer | Form DEFA14A | |
| 04/24/2026 3:07 PM | Immunome (1472012) Filer | Form ARS | |
| 04/03/2026 6:46 PM | Immunome (1472012) Issuer Rosett Max (1994071) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 6:48 PM | Higgins Jack (1993684) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 8:49 AM | Immunome (1472012) Subject Rosett Max (1994071) Reporting | Form 144/A | |
| 04/02/2026 10:46 AM | Immunome (1472012) Subject Rosett Max (1994071) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/02/2026 10:32 AM | Higgins Jack (1993684) Reporting Immunome (1472012) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/01/2026 4:39 PM | Higgins Jack (1993684) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 6:11 AM | Immunome (1472012) Issuer SIEGALL CLAY B (1167496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 10:43 AM | Immunome (1472012) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 8:23 PM | Immunome (1472012) Issuer WAGENHEIM PHILIP (1405684) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 11:56 AM | Immunome (1472012) Subject WAGENHEIM PHILIP (1405684) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/12/2026 5:05 AM | BIENAIME JEAN JACQUES (1221590) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 3:07 PM | Immunome (1472012) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/30/2025 5:47 PM | Immunome (1472012) Issuer SIEGALL CLAY B (1167496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:41 PM | Barchas Isaac (1808343) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 8:22 PM | Enavate Sciences GP, LLC (1953107) Filed by Immunome (1472012) Subject | Form SCHEDULE 13D/A | |
| 12/22/2025 6:43 AM | Higgins Jack (1993684) Reporting Immunome (1472012) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 6:32 AM | Immunome (1472012) Issuer Tsai Philip (2026600) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 6:38 AM | Immunome (1472012) Issuer SIEGALL CLAY B (1167496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:03 PM | Immunome (1472012) Issuer SIEGALL CLAY B (1167496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 3:45 PM | Immunome (1472012) Filer | Form 424B5 | |
| 12/17/2025 3:49 PM | Immunome (1472012) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/15/2025 3:24 PM | Immunome (1472012) Filer | Form 424B5 | |
| 12/15/2025 6:05 AM | Immunome (1472012) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |